THERAVANCE BIOPHARMA INC (TBPH) Stock Income Statement
USA - NASDAQ:TBPH - KYG8807B1068 - Common Stock
18.04 USD
+0.65 (+3.74%)
18.03 USD
-0.01 (-0.06%)
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 80.33M | 64.38M | 57.42M | 51.30M | 55.30M | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | 113.14M | 106.82M | 110.72M | 130.40M | 293.00M | |||
| Research and Development | 39.51M | 37.64M | 40.62M | 63.40M | 192.30M | |||
| Selling, General, and Administrative Expenses | 73.63M | 69.17M | 70.09M | 67.10M | 100.70M | |||
| Operating Income | -32.81M | -42.44M | -53.29M | -79.10M | -237.70M | |||
| Interest Income/Expense | 80.05M | 2.33M | 6.77M | 2.20M | -7.40M | |||
| Other Income/Expense | null | null | null | 0 | 0 | |||
| Non Recurring Items | null | -4.51M | -2.74M | -15.90M | -20.10M | |||
| Income Before Taxes | 47.24M | -44.61M | -49.27M | -92.80M | -265.20M | |||
| Income Tax | 17.90M | 11.80M | 5.92M | 0 | -200.00K | |||
| Net Income | 29.34M | -56.42M | -55.19M | 872.10M | -199.40M | |||
| EBITDA | -34.53M | -40.73M | -51.29M | -75.38M | -231.79M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.5625999999999998 | -1.155 | -0.998 | 11.84 | -2.86 | |||
| Non GAAP EPS | -1.05 | -1.09 | -0.9700000000000001 | -0.6699999999999999 | -2.95 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Profit Margin | 36.53% | -87.63% | -96.11% | 1700.00% | -360.58% | |||
| Operating Profit Margin | -40.85% | -65.91% | -92.80% | -154.19% | -429.84% | |||
All data in USD